Transcription of Public Assessment Report Decentralised Procedure …
{{id}} {{{paragraph}}}
Example: stock market
Public Assessment Report Decentralised Procedure …
1 Public Assessment Report Decentralised Procedure ONDANSETRON 2MG/ML SOLUTION FOR INJECTION UK/H/1240/01/DC UK Licence No: PL 20568/0009 CLARIS LIFESCIENCES UK LIMITED PAR Ondansetron 2mg/ml Solution for Injection UK/H/1240/01/DC 2 LAY SUMMARY On 23rd July 2009, the UK granted Claris Lifesciences UK Limited a Marketing Authorisation (licences) for the medicine Ondansetron 2mg/ml Solution for Injection. Ondansetron injection is a clear solution containing the active ingredient ondansetron, which is an anti-emetic (prevents nausea [feeling sick] and vomiting).
PAR Ondansetron 2mg/ml Solution for Injection UK/H/1240/01/DC 2 LAY SUMMARY On 23rd July 2009, the UK granted Claris Lifesciences UK Limited a Marketing Authorisation (licences) for the medicine Ondansetron 2mg/ml Solution for Injection.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: